Northern Trust Corp Ocugen, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 566,005 shares of OCGN stock, worth $582,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares

566,005

Previous 2,349,428 75.91%

Holding current value

$582,985

Previous $1.67 Million 67.09%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$0.58 - $1.2 $1.03 Million - $2.14 Million	-1,783,423 Reduced 75.91%	566,005 $549,000
Q1 2025 May 13, 2025	SELL	$0.52 - $0.9 $30,008 - $51,938	-57,709 Reduced 2.4%	2,349,428 $1.67 Million
Q4 2024 Feb 14, 2025	BUY	$0.72 - $1.08 $163,548 - $245,322	227,150 Added 10.42%	2,407,137 $1.93 Million
Q3 2024 Nov 13, 2024	BUY	$0.98 - $1.95 $1.52 Million - $3.03 Million	1,555,980 Added 249.35%	2,179,987 $2.16 Million
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.98 $135,334 - $227,086	114,690 Added 22.52%	624,007 $967,000
Q1 2024 May 14, 2024	SELL	$0.5 - $1.83 $216 - $790	-432 Reduced 0.08%	509,317 $835,000
Q4 2023 Feb 13, 2024	BUY	$0.36 - $0.57 $23,326 - $36,933	64,796 Added 14.56%	509,749 $290,000
Q3 2023 Nov 13, 2023	BUY	$0.4 - $0.62 $22,045 - $34,170	55,113 Added 14.14%	444,953 $177,000
Q2 2023 Aug 11, 2023	SELL	$0.45 - $0.88 $640,481 - $1.25 Million	-1,423,292 Reduced 78.5%	389,840 $210,000
Q1 2023 May 15, 2023	SELL	$0.82 - $1.33 $53,859 - $87,357	-65,682 Reduced 3.5%	1,813,132 $1.54 Million
Q4 2022 Feb 13, 2023	SELL	$1.11 - $1.87 $137,536 - $231,706	-123,907 Reduced 6.19%	1,878,814 $2.44 Million
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $42,082 - $74,545	-24,047 Reduced 1.19%	2,002,721 $3.57 Million
Q2 2022 Aug 12, 2022	BUY	$1.83 - $3.45 $480,698 - $906,235	262,677 Added 14.89%	2,026,768 $4.6 Million
Q1 2022 May 13, 2022	SELL	$2.34 - $4.72 $181,689 - $366,484	-77,645 Reduced 4.22%	1,764,091 $5.82 Million
Q4 2021 Feb 08, 2022	SELL	$4.38 - $15.67 $30,900 - $110,551	-7,055 Reduced 0.38%	1,841,736 $8.38 Million
Q3 2021 Nov 15, 2021	SELL	$6.36 - $8.51 $392,475 - $525,152	-61,710 Reduced 3.23%	1,848,791 $13.3 Million
Q2 2021 Aug 13, 2021	BUY	$5.52 - $15.68 $8.56 Million - $24.3 Million	1,551,299 Added 431.87%	1,910,501 $15.3 Million
Q1 2021 May 12, 2021	BUY	$1.66 - $15.81 $88,119 - $839,258	53,084 Added 17.34%	359,202 $2.44 Million
Q4 2020 Feb 11, 2021	BUY	$0.28 - $2.6 $47,447 - $440,580	169,454 Added 123.99%	306,118 $560,000
Q3 2020 Nov 16, 2020	BUY	$0.2 - $0.72 $19,240 - $69,265	96,202 Added 237.76%	136,664 $42,000
Q2 2020 Aug 14, 2020	SELL	$0.22 - $0.46 $339 - $709	-1,542 Reduced 3.67%	40,462 $9,000
Q1 2020 May 14, 2020	BUY	$0.26 - $0.73 $10,921 - $30,662	42,004 New	42,004 $12,000

Others Institutions Holding OCGN

# of Institutions

109

Shares Held

62.8M

Call Options Held

200K

Put Options Held

151K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $223M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Ocugen, Inc. Transaction History